US Stock MarketDetailed Quotes
IOBT IO Biotech
- 0.890
- +0.040+4.71%
Close Nov 29 13:00 ET
- 0.910
- +0.020+2.25%
Post 17:01 ET
58.63MMarket Cap-689P/E (TTM)
0.908High0.850Low294.81KVolume0.880Open0.850Pre Close260.88KTurnover1.06%Turnover RatioLossP/E (Static)65.88MShares2.09852wk High0.81P/B24.78MFloat Cap0.66052wk Low--Dividend TTM27.84MShs Float17.880Historical High--Div YieldTTM6.80%Amplitude0.660Historical Low0.884Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
IO Biotech Stock Forum
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...
loading...
No comment yet